- Investing Ideas
- Belgian Pharmaceuticals & Biotech Price disconnect
Belgian Pharmaceuticals & Biotech Price disconnect
Results
2
0 new
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
2 companies
UCB
Market Cap: €48.8b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€256.60
7D
3.0%
1Y
52.0%
argenx
Market Cap: €48.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€781.80
7D
2.5%
1Y
63.5%